From Name:
From Email:
To Name:
To Email:

Optional Message:


50 Percent of Pharmaceutical Companies Employ Dedicated Counter-Generics Teams

from BusinessWire

Nearly 75 percent of surveyed Top 10 and Top 50 pharmaceutical companies use a dedicated counter-generics team structure, revealed a Cutting Edge Information study. Counter-generics teams, whether dedicated to the task or created as-needed for each project, are necessary for any pharmaceutical company facing a product’s patent expiration. The study, “Post-Patent Generic and Biosimilar Defense: Harnessing Competitive Tactics to Mitigate Revenue Erosion,” found that over half of all surveyed companies maintain a dedicated structure for counter-generics planning and implementation. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063